70867-37-7Relevant articles and documents
Iridium-Triggered Allylcarbamate Uncaging in Living Cells
Gupta, Ajay,Gupta, Shalini,Mahawar, Pritam,Prasad, Puja,Sasmal, Pijus K.,Singh, Neelu
supporting information, p. 12644 - 12650 (2021/09/06)
Designing a metal catalyst that addresses the major issues of solubility, stability, toxicity, cell uptake, and reactivity within complex biological milieu for bioorthogonal controlled transformation reactions is a highly formidable challenge. Herein, we report an organoiridium complex that is nontoxic and capable of the uncaging of allyloxycarbonyl-protected amines under biologically relevant conditions and within living cells. The potential applications of this uncaging chemistry have been demonstrated by the generation of diagnostic and therapeutic agents upon the activation of profluorophore and prodrug in a controlled fashion within HeLa cells, providing a valuable tool for numerous potential biological and therapeutic applications.
N-methylimidazole-catalyzed synthesis of carbamates from hydroxamic acids via the lossen rearrangement
Yoganathan, Sabesan,Miller, Scott J.
supporting information, p. 602 - 605 (2013/04/11)
An efficient, one-pot, N-methylimidazole (NMI) accelerated synthesis of aromatic and aliphatic carbamates via the Lossen rearrangement is reported. NMI is a catalyst for the conversion of isocyanate intermediates to the carbamates. Moreover, the utility of arylsulfonyl chloride in combination with NMI minimizes the formation of often-observed hydroxamate-isocyanate dimers during the sequence. Under the present conditions, lowering of temperatures is also possible, enabling a mild protocol.
Degradative rearrangements of N-(t-butyloxycarbonyl)-O-methanesulfonyl- hydroxamic acids: A novel, reagent-based alternative to the Lossen rearrangement
Stafford, Jeffrey A.,Gonzales, Stephen S.,Barrett, David G.,Suh, Edward M.,Feldman, Paul L.
, p. 10040 - 10044 (2007/10/03)
-
